Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna. It employs 400 people in Austria, Scotland and the United States.

Anubis Bio has USPTO patented Microbiome-Cleanser (TM) natural food platform that quickly resolves GI-distress-diarrhea in animals starting with dogs (www.doggystat.com). Two major B2B distribution partnerships signed in 2021.

Emergent BioSolutions Canada, Inc. operates as a biopharmaceutical company that develops and manufactures immune therapeutic drugs. The company is headquartered in Winnipeg, Canada.

Arkion Life Sciences LLC is an American private company located in New Castle, DE, with a presence in US. The firm manufactures and supplies biotechnology products.

Innocent Biopharma develops and distributes the latest generation of antivenoms. Antivenom is indicated for the treatment of sub-saharan snake bites. It is a sterile, highly purified lyophilized preparation of equine immunoglobulin fragments neutralizing with the venoms of the following species that are viperidae, echis ocellatus, echis leucogaster, echis pyramidum, bitis arietans, bitis rhinoceros, bitis nasicornis, bitis gabonica, and elapidae, dendroaspis polylepis, dendroaspis viridis, dendroaspis angusticeps, dendroaspis jamesoni, naja nigricollis, naja melanoleuca, naja haje, naja pallida, naja nubiae, naja katiensis, naja senegalensis.

Part of Valneva SE, VALNEVA Austria GmbH is a company headquartered in Vienna, Austria, that operates as a biotechnology company which develops and commercializes vaccines for infectious diseases. It was founded in 2013. Frédéric Jacotot, Thomas Lingelbach and Franck Charles Marie Grimaud are the current co-CEOs of the firm.

Part of ADMA Biologics, Inc., ADMA BioManufacturing LLC is a company headquartered in Boca Raton, FL, that manufactures and wholesales pharmaceutical products.

Grifols Worldwide Operations Ltd. manufactures and develops pharmaceutical products. The company was founded in 2013 and is headquartered in Dublin, Ireland.

Immuron Ltd. engages in the research and development of oral immunotherapy, which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment is involved in research and development projects performed in Australia, Israel, and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.

US Agriculture LLC provides investment services. It operates and manage farmland assets and portfolios, develop and implement farmland investment strategies, underwrite and acquire farmland assets across a variety of regions and crop types, develop and implement efficient and effective reporting processes, design and implement investment policies, develop and implement asset allocation strategies, create and implement tools for market and asset targeting, and create and implement portfolio optimization tools and processes. The company was founded in 2015 and is headquartered in Indianapolis, IN.

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Laboratorios Silanes SA de CV manufactures and sells pharmaceutical products. The company engages in the development of pharmaceuticals. It offers various prescription products in therapeutic areas, such as multivitamins, cardiovascular diseases, diabetes, and anti-inflammatory medicines. The company was founded in 1943 and is headquartered in Mexico City, Mexico.

Integrated BioTherapeutics is a biotechnology company that focuses on discovering novel vaccines and therapeutics for emerging infectious diseases. Its antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines, and a variety of other product candidates for emerging viruses.

KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. It operates through the Pharmaceuticals and Environment Businesses. The Pharmaceutical business provides cell and gene therapeutics. The Environment business offers antibacterial and water treatment agents. The company was founded on April 21, 2000 and is headquartered in Seoul, South Korea.

TissueGene is a Maryland-based biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders. Founded in 1999, the company’s core technology employs a form of cell therapy to deliver therapeutic proteins directly to localized areas of damaged tissue. The sustained expression of such proteins initiates rapid repair of injured tissue without the need for invasive surgical procedures. TissueGene is currently developing four product candidates, TG-C, TG-B, TG-D, and TG-N for the regeneration of cartilage, bone, disc, and nerve, respectively. The company's lead product candidate, TG-C, has been developed for treating osteoarthritis of the knee and is currently in Phase II trials in the US and in Phase III trials in Korea.

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.